突发！这家biotech管理层“大换血”

市场资讯03-24

（来源：一度医药）据周一发布的证券文件显示，生物科技领域的收购专家Kevin Tang正在巩固其对Aurinia Pharmaceuticals的控制权，公司首席执行官（CEO）及核心管理团队（C-suite）均被替换，企业管理层迎来大洗牌。作为Aurinia董事会主席，Kevin Tang直接任命自己为公司新任CEO。同时，其旗下唐资本管理公司（Tang Capital Management）的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2621034977?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-24 10:23","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2621034977","market":"sg","top_or_hot":-1,"title":"突发！这家biotech管理层“大换血”","media":"市场资讯","content":"<div>\n<p>（来源：一度医药）据周一发布的证券文件显示，生物科技领域的收购专家Kevin Tang正在巩固其对Aurinia Pharmaceuticals的控制权，公司首席执行官（CEO）及核心管理团队（C-suite）均被替换，企业管理层迎来大洗牌。作为Aurinia董事会主席，Kevin Tang直接任命自己为公司新任CEO。同时，其旗下唐资本管理公司（Tang Capital Management）的...</p>\n\n<a href=\"https://finance.sina.com.cn/wm/2026-03-24/doc-inhrzysw0589071.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>突发！这家biotech管理层“大换血”</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n突发！这家biotech管理层“大换血”\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-24 10:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/wm/2026-03-24/doc-inhrzysw0589071.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>（来源：一度医药）据周一发布的证券文件显示，生物科技领域的收购专家Kevin Tang正在巩固其对Aurinia Pharmaceuticals的控制权，公司首席执行官（CEO）及核心管理团队（C-suite）均被替换，企业管理层迎来大洗牌。作为Aurinia董事会主席，Kevin Tang直接任命自己为公司新任CEO。同时，其旗下唐资本管理公司（Tang Capital Management）的...</p>\n\n<a href=\"https://finance.sina.com.cn/wm/2026-03-24/doc-inhrzysw0589071.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1992135399.USD","symbol_name":"Allianz Global Intelligent Cities AT Acc USD","start_time":0,"source_url":"https://finance.sina.com.cn/wm/2026-03-24/doc-inhrzysw0589071.shtml","article_id":"2621034977","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621034977","pubTimestamp":1774318980,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"此事发酵后，George Tidmarsh与Kevin Tang的过往交集随即被曝光。Aurinia随后对这位FDA官员提起诉讼，指控其发布“虚假且诽谤性的言论”，并声称Tidmarsh因与Kevin Tang存在长期个人积怨而刻意针对公司。据悉，二人曾一同供职于La Jolla Pharmaceutical，彼时Kevin Tang推动罢免了时任CEO的Tidmarsh，Aurinia在诉讼中称，Tidmarsh是利用其FDA的职位展开报复。目前，George Tidmarsh已于去年11月从FDA辞职，并表示将全力应诉这场诉讼。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU1992135472.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES \"AT\" (HKD) ACC","BK4588":"碎股","LABU":"三倍做多标普生物-Direxion","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","BK4198":"医疗保健用品","BK4585":"ETF&股票定投概念","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","CEO":"中海油","COO":"库珀医疗","LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","CFO":"VictoryShares US 500 Enhanced Volatility Wtd ETF","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC"},"translate_title":"Burst! This biotech's management \"big change of blood\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CEO":1,"CFO":1,"LABU":0.6,"COO":1},"content_text":"（来源：一度医药）据周一发布的证券文件显示，生物科技领域的收购专家Kevin Tang正在巩固其对Aurinia Pharmaceuticals的控制权，公司首席执行官（CEO）及核心管理团队（C-suite）均被替换，企业管理层迎来大洗牌。作为Aurinia董事会主席，Kevin Tang直接任命自己为公司新任CEO。同时，其旗下唐资本管理公司（Tang Capital Management）的高管Ryan Cole、Michael Hearne分别出任首席运营官（COO）、首席财务官（CFO）；唐资本的董事总经理Thomas Wei也被任命为首席科学官（CSO），上述人事任命均已在美国证券交易委员会（SEC）文件及相关新闻稿中披露。此次人事调整中，Aurinia原管理团队于上周五集体被解雇，涉及原CEO Peter Greenleaf、原COO Matthew Donley、原CFO Joseph Miller以及首席医疗官Gregory Keenan。事实上，Aurinia的高层动荡并非首次出现。公司核心业务为狼疮药物的研发与销售，但在2024年砍掉了大部分研发项目后，公司的研发管线仅剩基础布局，发展前景一度引发投资方不满。作为知名激进投资者，Kevin Tang素有主动发起收购的履历。2024年，因Aurinia遭遇研发挫折，且始终未能找到合适的收购方，投资方怨声载道，Kevin Tang也借此机会加入公司董事会。彼时，原CEO Peter Greenleaf曾提出辞职，但被董事会挽留，如今仍难逃被解雇的结局。值得关注的是，Aurinia近期还卷入了FDA的相关争议。去年9月，CDER主任George Tidmarsh在一条后续被删除的社交媒体帖子中公开点名Aurinia，直斥其狼疮药物Lupkynis疗效存疑。他在帖中表示，尽管该药物于2021年获得FDA加速批准、2024年拿到完全批准，但目前尚无证据表明其能为患者带来直接的临床获益。此事发酵后，George Tidmarsh与Kevin Tang的过往交集随即被曝光。Aurinia随后对这位FDA官员提起诉讼，指控其发布“虚假且诽谤性的言论”，并声称Tidmarsh因与Kevin Tang存在长期个人积怨而刻意针对公司。据悉，二人曾一同供职于La Jolla Pharmaceutical，彼时Kevin Tang推动罢免了时任CEO的Tidmarsh，Aurinia在诉讼中称，Tidmarsh是利用其FDA的职位展开报复。目前，George Tidmarsh已于去年11月从FDA辞职，并表示将全力应诉这场诉讼。来源：endpoints news\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2621034977","isCrawlerRequest":true}